Dojolvi

Ultragenyx earns 2 rare disease drug approvals—and a validated commercial strategy
Fierce Pharma
Fri, 01/29/21 - 10:00 am
Ultragenyx
FDA
Crysvita
tumor-induced osteomalacia
Kyowa Kirin
Dojolvi
Ultragenyx Pharma Wins FDA’s First Drug Nod for Rare Metabolic Disorder
Xconomy
Tue, 06/30/20 - 11:35 pm
Ultragenyx
FDA
long-chain fatty acid oxidation disorders
Dojolvi